#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Andersen-Tawil syndrome Langerhans' cell histiocytosis Spinal cord injury Astrocytoma malignant Sjogren's syndrome Prophylaxis against transplant rejection Antiphospholipid syndrome Breast angiosarcoma Hepato-lenticular degeneration Autoimmune myositis B-cell lymphoma Follicle centre lymphoma follicular grade I, II – III Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Demyelination Gastrointestinal neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Trials in Disease Piriformis syndrome – Basic Information Bronchopulmonary dysplasia Testicular leiomyosarcoma – Basic Information Mantle cell lymphoma refractory – Basic Information Angelman’s syndrome – Trials in Disease Retinitis pigmentosa – Basic Information Congenital hypotransferrinaemia – Basic Information Paroxysmal nocturnal haemoglobinuria Gaucher’s disease type I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    XENON (133XE) Letermovir Toldc Eftrenonacog Alfa Esflurbiprofen Gadobutrol Delandistrogene Moxeparvovec Human Vaccinia Immunoglobulin Lib-01 Monohydrate Mometasone Furoate Protease Arachis Hypogaea Flour GSKVX000000030918 HLX43 Idarubicin Hydrochloride SAR443820 Atropine Sulfate Monohydrate Cibotercept IBUZATRELVIR Thiamine Hydrochloride More therapies…

    Learn about Your Condition

    End stage renal disease Pemphigus Ovarian epithelial cancer Graft versus host disease Febrile neutropenia Pseudoxanthoma elasticum Takayasu's arteritis Antisynthetase syndrome Myofascial pain syndrome Postpartum haemorrhage Pancreatic fistula Cytomegalovirus infection Reperfusion injury Atrophic vulvovaginitis Hypertrophic scar More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinički bolnički centar Zagreb (University Hospital…

Klinički bolnički centar Zagreb (University Hospital Center Zagreb)

Vinogradska Cesta 29, Zagreb, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Elranatamab
    • Bortezomib
    • Carfilzomib
    Belgium Croatia Czechia Denmark Finland France +10

  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Secondary progressive multiple sclerosis
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Anhydrous Cholestyramine
    • Magnetic Resonance Imaging Contrast Media
    • Teriflunomide
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Austria Bulgaria Croatia Czechia Germany Greece +9

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

  • Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Adagrasib
    • Pembrolizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Croatia Denmark Hungary +8

  • Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Belgium Bulgaria Croatia Czechia Denmark France +9

  • Study of INCB099280 for Patients With Advanced Cutaneous Squamous Cell Carcinoma Not Suitable for Surgery or Radiotherapy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Skin squamous cell carcinoma metastatic
    • Skin squamous cell carcinoma recurrent
    Investigated Drugs:
    • Incb099280
    Croatia Finland France Hungary The Netherlands Romania +1
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!